ARTICLE | Clinical News
Zomig zolmitriptan neurology data
September 26, 2005 7:00 AM UTC
In a double-blind study in 334 patients, 2.5 mg Zomig was superior to placebo to treat menstrual migraine. Specifically, Zomig led to a higher 2-hour headache response (66% vs. 33%; p<0.001) and 2-hou...